Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mPower
NCT05995275Phase 2Completed
- Sponsor
- Moderna Inc
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mRNA-1769 in smallpox, mpox, sponsored by Moderna Inc. Started Aug 2023; status: completed.
02
Drugs
mRNA-1769
03
Conditions
smallpoxmpox
Beyond the preview
Go deeper on NCT05995275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995275.